Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 145 Gemcitabine 141 Oxaliplatin 135 Capecitabine 133 Leucovorin 107 Irinotecan 99 Bevacizumab 92 Cetuximab 69 Cisplatin 67 pembrolizumab 61 Radiotherapy 60 Nivolumab 41 130-nm albumin-bound paclitaxel 41 Sorafenib 39 Docetaxel 34 Albumin-Bound Paclitaxel 31 Radiosurgery 28 Paclitaxel 27 Surgical Procedures, Operative 25 regorafenib 24 Erlotinib Hydrochloride 23 Panitumumab 22 Cyclophosphamide 21 Celecoxib 20 Trastuzumab 19 Radiation 18 Neoadjuvant Therapy 18 IFL protocol 18 atezolizumab 17 Carboplatin 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × orantinib × Gastrointestinal × Clear all

NCT01465464 2019-08-07

ORIENTAL

Taiho Pharmaceutical Co., Ltd.

Phase 3 Terminated

888 enrolled 12 charts

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡